Targeting polycomb-mediated epigenetic silencing in T cell acute lymphoblastic leukemia |
Vanderbilt University Medical Center / Emmanuel Volanakis |
Young Investigator Grants |
2011 |
Tennessee |
Genomic Alterations in Medulloblastoma
|
Children’s Hospital Los Angeles / Shahab Asgharzadeh, MD |
Young Investigator Grants |
2008 |
California |
Anti-Angiogenic Effects of BAI Proteins in Neuroblastoma
|
Children’s Hospital of Philadelphia / Naomi Balamuth, MD |
Young Investigator Grants |
2006 |
Pennsylvania |
Elucidating Mechanisms Driving Renal Medullary Carcinomas to Deliver a Rational Approach to Cancer
Directed Therapy
|
Dana-Farber Cancer Institute / Andrew Hong, MD |
Young Investigator Grants |
2015 |
Massachusetts |
Development and Characterization of Novel Models of Human Osteosarcoma Development and Metastasis |
University of Minnesota / Beau Webber, PhD |
Young Investigator Grants |
2017 |
Minnesota |
Using Neurofibromatosis-1 (NF1) to understand Pediatric Brain Tumor Initiation |
MD Anderson Cancer Center / Yuan Pan, PhD |
Young Investigator Grants |
2020 |
Texas |
Dissecting the Hierarchy of Tumor Cell Differentiation Using Dual Recombinase Technology in a Novel Mouse Model of Rhabdomyosarcoma |
Duke University Medical Center / David Van Mater, MD, PhD |
Young Investigator Grants |
2013 |
North Carolina |
Reciprocal interactions between tumor killer dendritic cells and tumor-induced regulatory T lymphocytes
|
University of Arizona / Nicolas Larmonier, PhD |
Young Investigator Grants |
2008 |
Arizona |
Effect of SLCO Polymorphisms on High-Dose Methotrexate Clearance in Pediatric Oncology Patients |
Vanderbilt University Medical Center / Rachael Schulte, MD |
Young Investigator Grants |
2018 |
Tennessee |
Mechanisms of CNOT3 Tumor Suppression in T-ALL and Identification of New Drugs That Specifically Kill CNOT3-Deficient T-ALL Cells |
Dana-Farber Cancer Institute / Zhaodong Li, PhD |
Young Investigator Grants |
2014 |
Massachusetts |